HCPCS Service Codes - Medical care

HCPCS Codes for Medical care

• G9133

  Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)

• G9134

  Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)

• G9135

  Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)

• G9136

  Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)

• G9137

  Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)

• G9138

  Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)

• G9139

  Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)

• G9140

  Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours

• G9143

  Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

• G9148

  National committee for quality assurance - level 1 medical home

• G9149

  National committee for quality assurance - level 2 medical home

• G9150

  National committee for quality assurance - level 3 medical home

• G9151

  Mapcp demonstration - state provided services

• G9152

  Mapcp demonstration - community health teams

• G9153

  Mapcp demonstration - physician incentive pool

• G9156

  Evaluation for wheelchair requiring face to face visit with physician

• G9157

  Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes

• G9158

  Motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

• G9159

  Spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

• G9160

  Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

• G9161

  Spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

• G9162

  Spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

• G9163

  Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

• G9164

  Spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

• G9165

  Attention functional limitation, current status at therapy episode outset and at reporting intervals

• G9166

  Attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

• G9167

  Attention functional limitation, discharge status at discharge from therapy or to end reporting

• G9168

  Memory functional limitation, current status at therapy episode outset and at reporting intervals

• G9169

  Memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

• G9170

  Memory functional limitation, discharge status at discharge from therapy or to end reporting

• G9171

  Voice functional limitation, current status at therapy episode outset and at reporting intervals

• G9172

  Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

• G9173

  Voice functional limitation, discharge status at discharge from therapy or to end reporting

• G9174

  Other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

• G9175

  Other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

• G9176

  Other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

• G9186

  Motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

• G9187

  Bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including, but not limited to, assessment of safety, falls, clinical status, fluid status, medication reconciliation/management, patient compliance with orders/plan of care, performance of activities of daily living, appropriateness of care setting; (for use only in the meidcare-approved bundled payments for care improvement initiative); may not be billed for a 30-day period covered by a transitional care management code

• G9188

  Beta-blocker therapy not prescribed, reason not given

• G9189

  Beta-blocker therapy prescribed or currently being taken

• G9190

  Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)

• G9191

  Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)

• G9192

  Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

• G9193

  Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression

• G9194

  Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase

• G9195

  Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase

• G9196

  Documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled in clinical trials, patients with documented infection prior to surgical procedure of interest, patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics], patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics], other medical reason(s))

• G9197

  Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

• G9198

  Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

• G9199

  Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))